Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
top, with 10$ still a cheap cann specialist
skyrocket with a little volume...easy
cheapest cann stock currently ... easy
News of December 2017 officially confirmed today
https://www.bizjournals.com/sacramento/news/2017/12/19/marrone-bio-enters-deal-to-reduce-debt-by-72.html
Marrone Bio enters deal to reduce debt by 72 percent
By Victor A. Patton – Reporter, Sacramento Business Journal
Dec 19, 2017, 4:37pm
Davis-based biopesticide company Marrone Bio Innovations on Monday announced it's entering into a financing and debt restructuring agreement that’s expected to decrease the company’s debt by 72 percent.
During a Monday conference call with investors, CEO Pam Marrone called the agreement with lead investor Ospraie Ag Science LLC one of the most “significant milestones” in the company’s corporate history.
“The transactions announced today are expected to provide financial support for the company’s continued operations and growth goals for the foreseeable future,” Marrone said Monday. “This puts us in an extremely strong position to execute on our core business.”
Among the agreement’s highlights, New York-based Ospraie Ag Science will purchase around $30.7 million in shares and warrants, while other buyers will purchase $13.3 million.
The agreement is expected to convert $45 million of Marrone Bio’s debt to equity, with an effective conversion rate of $1.75 per share of common stock — reducing the company’s outstanding debt from $62.5 to $17.5 million.
If approved at the company’s annual stockholders meeting in January, the deal is expected to close in February.
Under the agreement, two new Class I members of the company’s board of directors will be designated by Ospraie Ag Science after the deal closes. Plus, Marrone Bio (Nasdaq: MBII) has agreed to the election of two Class II board members during the annual meeting of stockholders, according to a news release.
Investors reacted positively to the news Monday, as the company’s shares rose 15.79 percent to $1.10.
Marrone Bio makes biologically-based replacements for chemical pesticides.
unique major green supplier for cannabis crops
https://globenewswire.com/news-release/2017/06/12/1017746/0/en/California-Cannabis-Growers-Now-Have-Access-to-Safe-and-Effective-Biopesticides-From-Marrone-Bio-Innovations.html
DAVIS, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), (MBI) a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that three MBI active ingredients are now legal for use on cannabis crops in the California market.
Inclusion of these ingredients of products developed and owned by MBI on California Department of Pesticide Regulation’s newest posting of “Legal Pest Management Practices for Cannabis Growers in California,” (http://marronebioinnovations.com/wp-content/uploads/delightful-downloads/MC-mgmt-practices-092916-DPR-Cannabis-Approved-List.pdf) has made four MBI products with proven track records in many of California’s conventional and organic food crops, available to cannabis growers in California.
“We are pleased to meet the demand by the fast growing number of cannabis growers in California and many other states,” said Dr. Pam Marrone, Founder and Chief Executive Officer, Marrone Bio Innovations. “We are also currently working with industry experts around the country to develop cannabis-specific ‘special local need’ labels in states where it is currently legal to market and sell medicinal and/or adult use cannabis. Where allowed by state governments, these labels will provide product use information that is more detailed to cannabis cultivation practices.”
Marrone added, “We have seen the cannabis industry quickly emerge as an important segment for MBI. Our products are transforming cannabis production through the reduction of toxic chemicals and pesticide residues that are harmful to both the environment and to people.”
Natalie Darves, CEO of Cougar Acres Consulting and Lead Outdoor Horticulture Instructor, Oaksterdam University, commented, “California cannabis growers strive to produce a high quality and safe product. Since MBI products on the new CADPR listing are tolerance exempt, use of these pest management tools will help minimize crop rejection. Proposed cannabis testing standards prohibit unsafe pesticide residues from unapproved uses of synthetic pesticides. Since MBI products do not contain live microbes as active ingredients, I have been able to significantly reduce crop rejection. Most microbial pesiticides residues will not pass the stringent microbial contamination testing standards that exceed standard food safety testing. These various testing standards are the forefront of policy issues affecting California cannabis growers today. The MBI products approved for use on cannabis are valuable and welcome new tools for California growers.”
Reynoutria sachalinensis extract is the active component of Regalia biofungicide, bringing outstanding levels of control of diseases like powdery mildew and leaf spots. Chromobacterium subtsugae strain PRAA41T is the active ingredient in Grandevo bioinsecticide and Burkholderia spp. strain A396 is the active ingredient in Venerate XC bioinsecticide. These two bioinsecticides provide outstanding control of insects such as thrips, aphids, mites and white flies. Burkholderia spp. strain A396 is also the active element in Majestene bionematicide.
MBI products are safe for cannabis growers, their customers and the environment, and are approved for use in organic production. Further, these products are exempt from Maximum Residue Limits (MRL) and offer the flexibility to be used through point of harvest.
According to recent studies, the legal cannabis industry in the U.S. could grow to $50 billion in the next decade. It could expand to more than eight times its current size, as lawful cannabis suppliers gain new customers and convert consumers from the illicit market. The recent legalization of cannabis for adult use in California, where it was already permitted for medical use, is expected to triple the size of the country’s current $6 billion legal cannabis industry.
Rumors of an $AZFL connection (hemp/cbd venture currently in Colorado) ??
Ready for a sweet day here. Looks like the marked are feeling the stocks with a nice earnings surprise this week!!
$MBII
The close here leaves this looking like a runner for tomorrow. Really surprised the markets didn't react earlier to those earnings yesterday. Glad I peaked!
I bought on the technicals...then say the earnings news from yesterday...then saw some of what they're working on. Wonder is this is on an update on the Brazil pilot....or maybe approval to use product for MJ crops in another state.
$MBII Just took a small entry until some DD.
I hadn't pegged this an an MJ stock. Hmmm...
$MBII Revs of first 9 months = half the market cap here. Not bad PPS for an entry...IMO.
Significant revenue increases and gross margins of 41%. Holy Moley...how did the markets miss this one?!?
MBII
Marrone Bio Innovations Raises $1 MM via Unsecured Promissory Note
SOURCE: https://www.dailymarijuanaobserver.com/single-post/2017/10/19/MBII-Marrone-Bio-Innovations-Raises-1-Million-Unsecured-Promissory-Note-Accredited-Investor-Dwight-Anderson
Marrone Bio Innovations, Inc. (NASDAQ:MBII) just filed an 8-K with the SEC to disclose that the company has taken a new loan for $1 million from an accredited investor via an unsecured promissory note. While shares of MBII are down slightly on the news, this loan should help the company shore up its balance sheet.
Just recently, the company announced positive results of field trials in Brazil that show its products are matching or beating chemical-based pesticides in key crops for pesticide use. The company officially got on our radar after announcing that its bio-based pest-management products were approved for use on cannabis plants in California.
On October 12, 2017, MBII sold Dwight W. Anderson an unsecured promissory note in the principal amount of $1,000,000.00. From the date of the closing through December 31, 2017, the note will bear interest at a rate of 1% per annum, payable in arrears on the maturity date, unless earlier converted into shares of MBII.
Thereafter, beginning January 1, 2018, the note will bear interest at a rate of 10% per annum, payable in arrears on the maturity date, unless earlier converted into shares of MBII common stock as described below.
"Any or all of the principal or accrued interest under the Note may be converted into shares of the Company’s common stock at a rate of one share of common stock per $1.00 of converting principal or interest, rounded down to the nearest share with any fractional amounts cancelled, at the election of the Lender by delivery of written notice to the Company. In addition, upon the consummation of a qualified equity financing of the Company prior to the Maturity Date, the aggregate outstanding principal balance of the Note and all accrued and unpaid interest thereon may convert, at the option of the Lender, into that number of the securities issued and sold in such financing, determined by dividing (a) such aggregate principal and accrued interest amounts, by (b) the purchase price per share or unit paid by the purchasers of the Company’s securities issued and sold in such financing. Notwithstanding the foregoing, Lender’s ability to affect any such conversions will be limited by applicable provisions governing issuances of shares of the Company’s common stock under the rules of The Nasdaq Capital Market, subject to the Company’s receipt of any applicable waivers thereof, and any amounts not issuable to the Lender in the Company’s equity securities as a result of this limitation will be payable in cash."
For the full 8-K filing, click here
ARDSLEY ADVISORY PARTNERS has filed a new 13G, reporting 12.1% ownership in $MBII - https://fintel.io/so/us/mbii
$50M offering filed on January 9th.
There's a huge dilutive offering coming.
Short Term Target $5
Disrupting agricultural biotechnology products in very large global market.
Strong Revenue, EBITDA... bottom line profit around the corner
Good Cash Position.
5 approved products.
Strong Pipe Line - pending more approval
MAY 26,2016 The agreement provides for a settlement payment to the class of $12,000,000, which will be paid by insurance carriers
MBII Bounce could hit at anytime. Charts are hard to read here.
Thursday, September 11, 2014
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Marrone Bio Innovations, Inc.Business Wire (Thu, Sep 11)Saxena White P.A. Files Securities Fraud Class Action Against Marrone Bio Innovations, Inc.Marketwired (Thu, Sep 11)Marrone Bio Innovations to Webcast its Presentation at the Credit Suisse Basic Materials ConferenceBusiness Wire (Thu, Sep 11)Hagens Berman Notifies Investors in Marrone Bio Innovations, Inc. of the November 4, 2014, Lead Plaintiff Class-Action DeadlineGlobeNewswire (Thu, Sep 11)8:32 am Marrone Bio Innovations receives patent for use of Chromobacterium to control corn rootworm larvae infestationBriefing.com (Thu, Sep 11)Marrone Bio Innovations Receives Patent for Use of Chromobacterium to Control Corn Rootworm Larvae InfestationGlobeNewswire (Thu, Sep 11)
not sure either,but got in this today.My reason is simply because I like the CEO credentials,doesn't strike me as an intentional wrongdoer.I know that sounds naive,maybe she's not the best businesswoman out there,but surely a good scientist and I'm okay with that for now.Hope my faith is not misplaced,time will tell!
Yesss Sr bounce in the making. MBII is going to run nice. $$$$
Well, looks like no one is interested in this stock here. I'm suprised to see this kind of drop in price and no one has anything to say about this company. uhhh the audit situation seems to be far worst then what i told. How long does an audit usually take before all is cleared up. I'm thinking jump in a little lower and hold for the long term. This puppy is going to fly back to the 5 and 6 range for this is an opportunity not to miss. The risk/reward here is excellent in my opinion don't take my work for it do your own DD
For now I'm on the sideline watching if it falls in the lows 2s I may initial a position. I could understand the drop but the end result of the investigation may not be has horrible as it sounds as for there is always the change of a human being making a bad mistake on something this important.
Not sure if the bottom is in yet, use caution imo.
http://www.thestreet.com/story/12866001/1/why-marrone-bio-innovations-mbii-stock-hit-a-one-year-low-today.html?puc=yahoo&cm_ven=YAHOO
Wow, what a great opportunity to make some $$$$ this month with stock. Buying on the dip=$$$$$$
$MBII recent news/filings
bullish
## source: finance.yahoo.com
Mon, 18 Aug 2014 22:02:54 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Wed, 13 Aug 2014 21:01:09 GMT ~ MARRONE BIO INNOVATIONS INC Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/140813/mbii10-q.html
*********************************************************
Mon, 11 Aug 2014 20:00:47 GMT ~ MARRONE BIO INNOVATIONS INC Files SEC form 8-K, Change in Directors or Principal Officers
read full: http://biz.yahoo.com/e/140811/mbii8-k.html
*********************************************************
Fri, 08 Aug 2014 10:50:08 GMT ~ Marrone Bio Innovations downgraded by Robert W. Baird
read full: http://finance.yahoo.com/q/ud?s=MBII
*********************************************************
Thu, 07 Aug 2014 20:08:57 GMT ~ MARRONE BIO INNOVATIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
read full: http://biz.yahoo.com/e/140807/mbii8-k.html
*********************************************************
$MBII charts
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$MBII company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/MBII/company-info
Ticker: $MBII
OTC Market Place: Not Available
CIK code: not found
Company name: Marrone Bio Innovations, Inc.
Incorporated In:
Business Description:
$MBII share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$MBII extra dd links
Company name: Marrone Bio Innovations, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MBII/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MBII/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MBII+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MBII+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MBII+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MBII/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MBII/news - http://finance.yahoo.com/q/h?s=MBII+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MBII/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MBII/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MBII/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MBII/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MBII/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MBII/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MBII/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MBII/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MBII+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MBII
DTCC (dtcc.com): http://search2.dtcc.com/?q=Marrone+Bio+Innovations%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Marrone+Bio+Innovations%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Marrone+Bio+Innovations%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MBII/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MBII
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MBII/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MBII/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MBII/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MBII/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MBII/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MBII/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MBII/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MBII&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MBII
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MBII/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MBII+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MBII+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MBII
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MBII
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MBII+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MBII/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MBII+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MBII.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MBII
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MBII/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MBII/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MBII/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MBII/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MBII
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MBII
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MBII:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MBII
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MBII
$MBII DD Notes ~ http://www.ddnotesmaker.com/MBII
Marrone Bio Innovations announces Regalia Maxx Biofungicide received international registrations and certification (MBII) : Co announced FMC, the exclusive Latin America distributor for its Regalia Maxx Biofungicide, has received new product registrations in El Salvador, Guatemala, and Honduras. These countries join Panama and Mexico in approving the use of Regalia Maxx in Latin America to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.
$16 Marrone Bio Innovations approves Marrone Bio Innovations' Zequanox for invasive mussel control (MBII) 15.96 -0.81 : Co announced that the state of California has issued a Certificate of Pesticide Registration for Zequanox to control invasive zebra and quagga mussels (Dreissena species) in pipe systems and infrastructure. Under this registration, Zequanox can now be used as an effective, environmentally responsible alternative to toxic, broad-spectrum chemicals (such as chlorine) to treat irrigation lines and water conveyance structures, as well as cooling and process water systems of industrial and power generation facilities.
'JG' I found MBII on the NASDAQ competitors list of POT,IPI (one of the two) and noticed the spike in the SP.Looking further left me a little puzzled also as I did not think the quarterly was strong.True 80million in debt isn't much,28 million float (shares outstanding) isn't much, BUT a bigger warehouse doesn't quite cut it for me as a picture of solid growth.They have Federal backing and all but I agree with you whole heartedly that the share price is out of bounds,even with the $60million gained from the offering to keep them financially afloat for the next twentyfour months. The SP spike came more on financial news not related to product. THE SP is overblown in my opinion. Will watch on a watch list.Thanks for repling 'JG'
Stanner, I found Marrone Bio Innovations (MBII) on www.NASDAQ.com in the "Latest IPOs" section. I made a board for MBII as "just cause". I'm currently only use one investment strategy, which is value investing. To a value investor such as myself, this stock looks unattractive. Besides being overvalued, I see a negative profit margin and debt. (Dilution)? I do notice growth, it seems progress is being made. I say this all, without looking at the financials and deep digging. This analysis, was simply just a quick glance. Possible further research could show more as to why they are not profitable and more on their debt situation.
Responding to your latest post. I do believe this is a high float for a company that is newly public. I'm not knowledge enough to comment further regarding their share structure and to what this means.
What do you think about MBII? You seem more knowledgeable then myself.
Apparently there is a 20 million+ or - share float for this new company.(sc13g==8/28)
Hey 'JG' what do we have here?
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
94
|
Created
|
09/04/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |